A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
from Top Health News -- ScienceDaily https://ift.tt/3gxFrI4
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Most of the world isn’t getting enough omega-3
Most people worldwide aren’t getting enough omega-3, leaving a major gap between scientific recommendations and daily diets. Researchers emp...
-
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one ...
-
Researchers observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster vi...
-
Researchers have identified nearly 300 genetic disorders that can be treated before or immediately after a baby is born. This 'treatable...
No comments:
Post a Comment